pyrazines has been researched along with sar 020106 in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Aherne, GW; Box, G; Boxall, KJ; Collins, I; De Haven Brandon, A; Eccles, SA; Eve, PD; Garrett, MD; Hayes, A; Raynaud, FI; Reader, JC; Valenti, M; Walton, MI; Williams, DH | 1 |
Borst, GR; Collins, I; Garrett, MD; Good, J; Harrington, KJ; Khan, A; Kyula, JN; McLaughlin, M; Meier, P; Neijenhuis, S; Powell, NG; Verheij, M; Zaidi, S | 1 |
Borst, G; Clayton, J; Collins, I; Federspiel, MJ; Garrett, M; Harrington, KJ; Karapanagiotou, EM; Khan, AA; Kyula, J; Mansfield, D; McLaughlin, M; Pencavel, T; Roulstone, V; Russell, SJ; Touchefeu, Y; Zaidi, SH | 1 |
3 other study(ies) available for pyrazines and sar 020106
Article | Year |
---|---|
The preclinical pharmacology and therapeutic activity of the novel CHK1 inhibitor SAR-020106.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Camptothecin; Cell Death; Cell Line, Tumor; Checkpoint Kinase 1; Deoxycytidine; DNA Damage; Drug Synergism; G2 Phase; Gemcitabine; Humans; Irinotecan; Isoquinolines; Mice; Mice, Nude; Mutagens; Phosphorylation; Protein Kinase Inhibitors; Protein Kinases; Pyrazines; Xenograft Model Antitumor Assays | 2010 |
Targeted radiosensitization by the Chk1 inhibitor SAR-020106.
Topics: Animals; Apoptosis; Cell Cycle; Cell Line, Tumor; Checkpoint Kinase 1; Cyclin-Dependent Kinase Inhibitor p21; DNA Damage; DNA Repair; G2 Phase; HeLa Cells; Histones; Humans; Immunohistochemistry; Isoquinolines; Mice; Mice, Nude; Microscopy; Mitosis; Papillomaviridae; Protein Kinases; Pyrazines; Radiation Tolerance; Radiation-Sensitizing Agents; Time-Lapse Imaging; Tumor Stem Cell Assay; Tumor Suppressor Protein p53 | 2013 |
Optimising measles virus-guided radiovirotherapy with external beam radiotherapy and specific checkpoint kinase 1 inhibition.
Topics: Animals; Cell Line, Tumor; Checkpoint Kinase 1; Colorectal Neoplasms; Combined Modality Therapy; Head and Neck Neoplasms; Humans; Iodine Radioisotopes; Isoquinolines; Measles virus; Mice; Oncolytic Virotherapy; Protein Kinase Inhibitors; Protein Kinases; Pyrazines; Radiation-Sensitizing Agents; Symporters; Virus Replication; Xenograft Model Antitumor Assays | 2013 |